Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could This Be Pfizer's Next Billion-Dollar Vaccine?

TheMotleyFool

0 0

Could This Be Pfizer's Next Billion-Dollar Vaccine?: https://g.foolcdn.com/editorial/images/701124/person-getting-vaccinated.jpg

Pharma giant Pfizer (NYSE: PFE) gained in prominence in the past couple of years thanks to its COVID-19 vaccine, Comirnaty. The company has generated billions in sales from this product alone, although many investors now think this tailwind will soon end, as the demand for coronavirus vaccines could drop substantially starting next year.

However, Pfizer has several tricks up its sleeve. The company is currently working on another promising vaccine that may not become nearly as successful as Comirnaty, but could generate at least $1 billion in annual sales if approved. Let's look into this program and what it could mean for Pfizer.